Two Sigma Advisers
MTNB icon

Two Sigma Advisers’s Matinas BioPharma MTNB Stock Holding History

Two Sigma Advisers’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,086
Closed -$236K – 2598
2021
Q2 		$236K Sell
6,086
-4,474
-42% -$192K ﹤0.01% 2224
2021
Q1 		$554K Sell
10,560
-1,058
-9% -$71K ﹤0.01% 1971
2020
Q4 		$790K Sell
11,618
-8,320
-42% -$385K ﹤0.01% 1677
2020
Q3 		$764K Buy
19,938
+12,036
+152% +$479K ﹤0.01% 1621
2020
Q2 		$305K Buy
7,902
+5,858
+287% +$225K ﹤0.01% 2113
2020
Q1 		$61K Buy
+2,044
New +$123K ﹤0.01% 2362

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's MTNB Position: Q3 2021 in Review

Two Sigma Advisers sold out of Matinas BioPharma (MTNB) in Q3 2021, closing a stake of 6,086 shares — an estimated $236K sold.

Two Sigma Advisers first reported a position in MTNB in Q1 2020 and held it in 6 quarters. The position peaked at $790K in Q4 2020. 67 funds tracked by Wall St. Rank hold MTNB as of Q3 2021.

  • Two Sigma Advisers reported no remaining Matinas BioPharma position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 6,086 Matinas BioPharma shares in Q3 2021, an estimated $236K.
  • Two Sigma Advisers first reported a position in Matinas BioPharma in Q1 2020 and held it in 6 quarters.
  • Two Sigma Advisers's Matinas BioPharma position peaked at $790K in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.